# Whole-Genome Sequencing Analysis of Drug-Resistant Salmonella Typhi in Children

**Authors:** Muhammad Riaz, Shabir Ahmad, Fazal Sattar, Ganwu Li, Zia Ud Din, Sajjad Ahmad, Azra, Aiman Waheed, Ihtisham Ul Haq, Jody E. Phelan, Gulab Fatima Rani, Otavio Cabral-Marques, Susana Campino, Taj Ali Khan, Taane G. Clark

PMC · DOI: 10.3390/pathogens14100967 · Pathogens · 2025-09-24

## TL;DR

This study analyzed drug-resistant Salmonella Typhi in children using whole-genome sequencing to identify resistance genes and mutations.

## Contribution

The study provides new insights into the genetic basis of drug resistance in pediatric typhoid cases through whole-genome sequencing.

## Key findings

- 68% of isolates were XDR and 61% were MDR, showing resistance to multiple antibiotics.
- Key resistance genes like bla_CTX-M-15, bla_TEM-1B, and gyrA-S83F were identified in all sequenced isolates.
- The IncY plasmid was found in 14% of isolates and linked to resistance against ceftriaxone.

## Abstract

Typhoid fever, caused by Salmonella enterica subsp. enterica serovar Typhi (S. typhi), remains a major public health concern, particularly in low-resource settings with poor sanitation. The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains have significantly complicated treatment, especially in vulnerable pediatric populations. This study aimed to characterize the genetic profiles of drug resistance in MDR and XDR S. typhi isolates from pediatric patients. Methods: A cross-sectional study was conducted on 800 blood samples from pediatric typhoid patients. S. typhi isolates were identified using the BacT/ALERT 3D system, followed by culture on MacConkey and blood agar. Antimicrobial susceptibility was assessed using the disk diffusion method according to CLSI 2022 guidelines. Whole-genome sequencing (WGS) was performed on 29 isolates using Illumina MiSeq technology, and resistance genes and mutations were analyzed. Results: Antimicrobial susceptibility testing revealed that 68 (48.57%) of S. typhi isolates were XDR and 61 (43.57%) were MDR, exhibiting widespread resistance to ciprofloxacin, ampicillin, chloramphenicol, ceftriaxone, and co-trimoxazole. WGS identified key resistance genes across all 29 isolates, including bla_CTX-M-15, bla_TEM-1B, qnrS1, aac(6′)-Iaa, catA1, dfraA7, sul1, qacEΔ1, and the gyrA-S83F mutation. Notably, gyrA-S83F and qnrS1 were detected in all isolates and strongly correlated with ciprofloxacin resistance. Virulence genes were consistently present in all isolates, indicating a high pathogenic potential. The IncY plasmid, found in four (14%) isolates, was linked to resistance against third-generation cephalosporins, including ceftriaxone. Conclusion: This study underscores the alarming prevalence of MDR and XDR S. typhi isolates among pediatric patients, driven by resistance genes such as bla_CTX-M-15, bla_TEM-1B, and gyrA-S83F. These findings highlight the urgent need for targeted therapeutic strategies and robust surveillance systems to combat the growing threat of drug-resistant typhoid fever.

## Linked entities

- **Genes:** LOC110894757 (catalase-like) [NCBI Gene 110894757], sul-1 (Putative extracellular sulfatase Sulf-1 homolog) [NCBI Gene 180619]
- **Chemicals:** ciprofloxacin (PubChem CID 2764), ampicillin (PubChem CID 6249), chloramphenicol (PubChem CID 5959), ceftriaxone (PubChem CID 5479530), co-trimoxazole (PubChem CID 358641)
- **Diseases:** typhoid fever (MONDO:0005619)
- **Species:** Salmonella enterica subsp. enterica serovar Typhi (taxon 90370)

## Full-text entities

- **Diseases:** Typhoid fever (MESH:D014435), XDR (MESH:D054908)
- **Chemicals:** chloramphenicol (MESH:D002701), co-trimoxazole (MESH:D015662), blood agar (-), ciprofloxacin (MESH:D002939), cephalosporins (MESH:D002511), ceftriaxone (MESH:D002443), ampicillin (MESH:D000667)
- **Species:** Homo sapiens (human, species) [taxon 9606], Salmonella enterica subsp. enterica serovar Typhi (no rank) [taxon 90370]
- **Mutations:** S83F

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12566932/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12566932/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12566932/full.md

---
Source: https://tomesphere.com/paper/PMC12566932